Leukemia   

If yes, would you go with Zidovudine monotherapy versus combining with interferon-alpha? And what would be the preferred dose and duration? 

At the time of count recovery or do you continue it throughout induction and consolidation?

Can experts comment on fungal pneumonia risk with individual BTK inhibitors as seen in ELEVATE-RR and whether this impacts their management decisions?

Is it at neutrophil recovery, at documentation of CR on bone marrow biopsy, or is there a different point in time?